论文部分内容阅读
Transient ischemic attack(TIA) is an acute cerebrovascular incident,and is generally considered the best opportunity for early neuroprotective treatment against cerebral ischemia.This study retrospectively analyzed 80 patients with TIA(38 males and 42 females).Among 61 patients who received neuroprotective cerebrolysin treatment within 24 hours after TIA onset,13(21.31%) patients suffered subsequent strokes.Among 19 patients who received neuroprotective cerebrolysin treatment within 24-72 hours after TIA onset,seven(36.84%) developed cerebral infarction.There was a significant difference in the proportion of subsequent strokes between patients receiving cerebrolysin treatment within 24 hours and 24-72 hours after TIA onset(P = 0.438).These findings suggest that neuroprotective drugs administrated within 24 hours after TIA onset help reduce the incidence of subsequent strokes.The results demonstrate usefulness of the ABCD2 score at TIA patients in the determination of short-term and long-term cerebrovascular risk,including the frequency of subsequent ischemic cerebral infarctions up to 12 months.
Transient ischemic attack (TIA) is an acute cerebrovascular vascular incident, and is generally considered the best opportunity for early neuroprotective treatment against cerebral ischemia. This study retrospectively analyzed 80 patients with TIA (38 males and 42 females). Among 61 patients who received neuroprotective cerebrolysin Treatment within 24 hours after TIA onset, 13 (21.31%) patients suffered subsequent strokes. Among 19 patients who received neuroprotective cerebrolysin treatment within 24-72 hours after TIA onset, seven (36.84%) developed cerebral infarction. there was a significant difference in the proportion of subsequent strokes between patients receiving cerebrolysin treatment within 24 hours and 24-72 hours after TIA onset (P = 0.438). The findings suggest that neuroprotective drugs administrated within 24 hours after TIA onset help reduce the incidence of subsequent strokes.The results demonstrate usefulness of the ABCD2 score at TIA patients in the determination of short-term and lon g-term cerebrovascular risk, including the frequency of subsequent ischemic cerebral infarctions up to 12 months.